Roslindale, MA, United States of America

Richard Kream

This inventor holds 1 USPTO granted patent. Top assignee: New England Medical Center Hospitals. Inc.. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Kream. Retrieved from https://idiyas.com/inventor/richard-kream

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Richard Kream

Introduction

Richard Kream is an accomplished inventor based in Roslindale, MA (US). He has made significant contributions to the field of medical science, particularly in the development of novel analgesic compounds. His work focuses on creating innovative solutions to enhance pain management.

Latest Patents

Richard Kream holds a patent for "Chimeric analgesic peptides." This invention provides a novel chimeric peptide that contains both an opioid peptide moiety and a nociceptive peptide moiety, aimed at producing effective analgesia. This advancement has the potential to improve pain relief methods significantly.

Career Highlights

Kream is associated with New England Medical Center Hospitals, Inc., where he applies his expertise in medical research and innovation. His work at this institution has allowed him to explore and develop new therapeutic approaches to pain management.

Collaborations

Some of his notable coworkers include Daniel B Carr and Andrzej W Lipkowski. Their collaboration has contributed to the advancement of research in analgesic therapies.

Conclusion

Richard Kream's innovative work in the field of analgesic peptides showcases his commitment to improving pain management solutions. His contributions are valuable to both the medical community and patients seeking relief from pain.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…